Voloridge Investment Management
IGMS

Voloridge Investment Management’s IGM Biosciences IGMS Stock Holding History

Voloridge Investment Management’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-38,914
Closed -$885K – 1529
2022
Q3 		$885K Sell
38,914
-62,723
-62% -$1.27M ﹤0.01% 1180
2022
Q2 		$1.83M Sell
101,637
-60,852
-37% -$1.08M 0.01% 1039
2022
Q1 		$4.34M Buy
162,489
+65,015
+67% +$1.21M 0.02% 685
2021
Q4 		$2.86M Buy
+97,474
New +$4.84M 0.02% 932
2021
Q1 		– Sell
-9,024
Closed -$797K – 1520
2020
Q4 		$797K Sell
9,024
-20,898
-70% -$1.47M 0.01% 1030
2020
Q3 		$2.21M Buy
+29,922
New +$1.77M 0.02% 688

Other funds holding IGMS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Voloridge Investment Management's IGMS Position: Q4 2022 in Review

Voloridge Investment Management sold out of IGM Biosciences (IGMS) in Q4 2022, closing a stake of 38,914 shares — an estimated $885K sold.

Voloridge Investment Management first reported a position in IGMS in Q3 2020 and held it in 6 quarters. The position peaked at $4.34M in Q1 2022. 82 funds tracked by Wall St. Rank hold IGMS as of Q4 2022.

  • Voloridge Investment Management reported no remaining IGM Biosciences position as of Q4 2022 after selling out during the quarter.
  • Voloridge Investment Management sold 38,914 IGM Biosciences shares in Q4 2022, an estimated $885K.
  • Voloridge Investment Management first reported a position in IGM Biosciences in Q3 2020 and held it in 6 quarters.
  • Voloridge Investment Management's IGM Biosciences position peaked at $4.34M in Q1 2022.
  • 82 funds tracked by Wall St. Rank held IGM Biosciences as of Q4 2022.

Based on Voloridge Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.